Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells.
about
Identification of phosphatidylinositol 4-kinase type II beta as HLA class II-restricted target in graft versus leukemia reactivityExploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia.Identification of 4 novel HLA-B*40:01 restricted minor histocompatibility antigens and their potential as targets for graft-versus-leukemia reactivityNonhematopoietic antigen blocks memory programming of alloreactive CD8+ T cells and drives their eventual exhaustion in mouse models of bone marrow transplantation.A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy.Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantation.Can immunotherapy specifically target acute myeloid leukemic stem cells?Minor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactions.Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia.The graft-versus-neuroblastoma effect of allogeneic hematopoietic stem cell transplantation, a review of clinical and experimental evidence and a perspective on mechanisms.A Good Manufacturing Practice procedure to engineer donor virus-specific T cells into potent anti-leukemic effector cells.HLA class II restricted T-cell receptor gene transfer generates CD4+ T cells with helper activity as well as cytotoxic capacity.Development of T-cell immunotherapy for hematopoietic stem cell transplantation recipients at risk of leukemia relapse.Alloreaction increases or restores CD40, CD54, and/or HLA molecule expression in acute myelogenous leukemia blasts, through secretion of inflammatory cytokines: Dominant role for TNFbeta, in concert with IFNgamma.
P2860
Q24652244-C882E13F-A190-4A04-BC76-C511D3A2EB02Q34163218-CDD8C259-30F4-4AAF-9AC6-51077A6A08EAQ34196623-9CDEFB24-8C37-43A3-91B4-3F64331E3207Q34245299-5F5F57AB-6C1D-44AB-8A2D-F47EE29055E5Q34815702-40A9503C-AD90-4618-ABD0-4B0809A69330Q36662079-3ACFBF7B-BD05-4FF1-A605-6439B0ECE250Q36694901-E01A1B5E-6DC6-4E57-BD3D-40059D79E6C3Q36830199-DA298C45-404D-4458-A490-A72ABF69FBD9Q37447307-F780454B-F11D-403E-BFE2-A13621711147Q38243215-A9CD2B43-CEF2-44F6-B1CC-354ECF992376Q38572657-3E2A74DC-D1FB-413E-B497-50955A5FD32EQ45885235-90CAAAD3-EA65-4529-8D84-626B6EFAD614Q48523192-FAF038DF-3448-4518-8B17-550733CB9914Q51130137-90B962E9-3DDB-4253-92D5-03F1FD628EA0
P2860
Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Direct cloning of leukemia-rea ...... A-1 and HA-2 specific T cells.
@en
Direct cloning of leukemia-rea ...... A-1 and HA-2 specific T cells.
@nl
type
label
Direct cloning of leukemia-rea ...... A-1 and HA-2 specific T cells.
@en
Direct cloning of leukemia-rea ...... A-1 and HA-2 specific T cells.
@nl
prefLabel
Direct cloning of leukemia-rea ...... A-1 and HA-2 specific T cells.
@en
Direct cloning of leukemia-rea ...... A-1 and HA-2 specific T cells.
@nl
P2093
P2860
P356
P1433
P1476
Direct cloning of leukemia-rea ...... A-1 and HA-2 specific T cells.
@en
P2093
Falkenburg JH
Kloosterboer FM
Strijbosch MP
Willemze R
van Egmond HM
van Luxemburg-Heijs SA
P2860
P2888
P304
P356
10.1038/SJ.LEU.2403297
P577
2004-04-01T00:00:00Z